Polar Capital Biotechnology R EUR (IE00B3VXGD32)
62.21
+2.00
(+3.32%)
EUR |
Oct 27 2026
IE00B3VXGD32 Net Asset Value
Net Asset Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Asset Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 62.21 |
| October 23, 2026 | 60.21 |
| October 22, 2026 | 61.30 |
| October 21, 2026 | 60.80 |
| October 20, 2026 | 60.99 |
| October 19, 2026 | 59.15 |
| October 16, 2026 | 57.63 |
| October 15, 2026 | 59.18 |
| October 14, 2026 | 58.49 |
| October 13, 2026 | 57.82 |
| October 09, 2026 | 60.27 |
| October 08, 2026 | 58.92 |
| October 07, 2026 | 60.12 |
| October 06, 2026 | 59.91 |
| October 05, 2026 | 61.15 |
| October 02, 2026 | 61.39 |
| October 01, 2026 | 61.63 |
| September 30, 2026 | 62.07 |
| September 29, 2026 | 62.12 |
| September 28, 2026 | 62.41 |
| September 25, 2026 | 61.84 |
| September 24, 2026 | 62.10 |
| September 23, 2026 | 62.10 |
| September 22, 2026 | 64.30 |
| September 21, 2026 | 63.28 |
| Date | Value |
|---|---|
| September 18, 2026 | 63.23 |
| September 17, 2026 | 65.10 |
| September 16, 2026 | 64.11 |
| September 15, 2026 | 64.10 |
| September 14, 2026 | 66.03 |
| September 11, 2026 | 65.50 |
| September 10, 2026 | 65.53 |
| September 09, 2026 | 66.16 |
| September 08, 2026 | 67.12 |
| September 04, 2026 | 67.56 |
| September 03, 2026 | 67.87 |
| September 02, 2026 | 68.00 |
| September 01, 2026 | 67.09 |
| August 28, 2026 | 66.82 |
| August 27, 2026 | 68.84 |
| August 26, 2026 | 69.20 |
| August 25, 2026 | 69.06 |
| August 24, 2026 | 68.39 |
| August 21, 2026 | 68.56 |
| August 20, 2026 | 67.97 |
| August 19, 2026 | 70.02 |
| August 18, 2026 | 69.45 |
| August 17, 2026 | 68.79 |
| August 14, 2026 | 67.83 |
| August 13, 2026 | 67.87 |
Net Asset Value (NAV) Definition
Net Asset Value measures the total value of a security based on assets divided by shares outstanding. This metric is calculated by (Total Assets - Total Liabilities) / Shares Outstanding.
Net Asset Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Asset Value Benchmarks
| Allianz Biotechnologie - A - EUR | 271.42 |
| DWS ESG Biotech LC | 334.59 |
| ERSTE STOCK BIOTEC EUR R01 (T) | 664.74 |
| MEDICAL BioHealth EUR | 1005.20 |
| Pictet-Biotech-HP EUR | 836.66 |
Net Asset Value Excel Add-In Codes
| Metric Code: net_asset_value |
| Latest Data Point: =YCP("M:IE00B3VXGD32", "net_asset_value") |
| Last 5 Data Points: =YCS("M:IE00B3VXGD32", "net_asset_value", -4) |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |